Devos Yann, Craig Wendy, Devlin Robert H, Ippolito Alessio, Leggatt Rosalind A, Romeis Jörg, Shaw Richard, Svendsen Claus, Topping Christopher J
GMO Unit European Food Safety Authority (EFSA) Italy.
Biosafety Group International Centre for Genetic Engineering & Biotechnology (ICGEB) Italy.
EFSA J. 2019 Jul 8;17(Suppl 1):e170708. doi: 10.2903/j.efsa.2019.e170708. eCollection 2019 Jul.
Pre-market/prospective environmental risk assessments (ERAs) contribute to risk analyses performed to facilitate decisions about the market introduction of regulated stressors. Robust ERAs begin with an explicit problem formulation, which involves among other steps: (1) formally devising plausible pathways to harm that describe how the deployment of a regulated stressor could be harmful; (2) formulating risk hypotheses about the likelihood and severity of such events; (3) identifying the information that will be useful to test the risk hypotheses; and (4) developing a plan to acquire new data for hypothesis testing should tests with existing information be insufficient for decision-making. Here, we apply problem formulation to the assessment of possible adverse effects of RNA interference-based insecticidal genetically modified (GM) plants, GM growth hormone coho salmon, gene drive-modified mosquitoes and classical biological weed control agents on non-target organisms in a prospective manner, and of neonicotinoid insecticides on bees in a retrospective manner. In addition, specific considerations for the problem formulation for the ERA of nanomaterials and for landscape-scale population-level ERAs are given. We argue that applying problem formulation to ERA maximises the usefulness of ERA studies for decision-making, through an iterative process, because: (1) harm is defined explicitly from the start; (2) the construction of risk hypotheses is guided by policy rather than an exhaustive attempt to address any possible differences; (3) existing information is used effectively; (4) new data are collected with a clear purpose; (5) risk is characterised against well-defined criteria of hypothesis corroboration or falsification; and (6) risk assessment conclusions can be communicated clearly. However, problem formulation is still often hindered by the absence of clear policy goals and decision-making criteria (e.g. definition of protection goals and what constitutes harm) that are needed to guide the interpretation of scientific information. We therefore advocate further dialogue between risk assessors and risk managers to clarify how ERAs can address policy goals and decision-making criteria. Ideally, this dialogue should take place for all classes of regulated stressors, as this can promote alignment and consistency on the desired level of protection and maximum tolerable impacts across regulated stressors.
上市前/前瞻性环境风险评估(ERA)有助于进行风险分析,以促进有关受监管压力源市场引入的决策。稳健的ERA始于明确的问题表述,这包括以下步骤:(1)正式设计合理的危害途径,描述受监管压力源的部署可能如何造成危害;(2)就此类事件的可能性和严重性制定风险假设;(3)确定对检验风险假设有用的信息;(4)制定一项计划,以便在利用现有信息进行的检验不足以用于决策时获取新数据进行假设检验。在此,我们以前瞻性方式将问题表述应用于评估基于RNA干扰的杀虫转基因植物、转基因生长激素银大麻哈鱼、基因驱动修饰蚊子和经典生物杂草防治剂对非靶标生物可能产生的不利影响,并以回顾性方式评估新烟碱类杀虫剂对蜜蜂的影响。此外,还给出了纳米材料ERA问题表述以及景观尺度种群水平ERA的具体考虑因素。我们认为,通过迭代过程将问题表述应用于ERA可最大限度地提高ERA研究对决策的有用性,原因如下:(1)从一开始就明确界定危害;(2)风险假设的构建以政策为指导,而非试图详尽无遗地应对任何可能的差异;(3)有效利用现有信息;(4)有明确目的收集新数据;(5)根据明确界定的假设证实或证伪标准来表征风险;(6)能够清晰地传达风险评估结论。然而,由于缺乏指导科学信息解读所需的明确政策目标和决策标准(如保护目标的定义以及何为危害),问题表述往往仍受到阻碍。因此,我们主张风险评估人员和风险管理人员进一步开展对话,以阐明ERA如何能够实现政策目标和决策标准。理想情况下,这种对话应针对所有类别的受监管压力源进行,因为这有助于在期望的保护水平和受监管压力源的最大可容忍影响方面实现一致和连贯。